Enhancing the tolerance of poly(isobutylcyanoacrylate) nanoparticles with a modular surface design

International Journal of Pharmaceutics

Volumn 338, Issue 1-2, 2007, Pages 327-332

  Chauvierre, Cédric ^a   Leclerc, Liliane ^a   Labarre, Denis ^b   Appel, Martine ^b   Marden, Michael C ^a   Couvreur, Patrick ^b   Vauthier, Christine ^b  

^a BICÊTRE HOSPITAL   (France)

^b UNIV PARIS SUD   (France)

Author keywords

Cytotoxicity; Heamoglobin; Nanoparticles; Poly(alkylcyanoacrylate); Polysaccharide coating

Indexed keywords

DEXTRAN; HEMOGLOBIN; NANOPARTICLE; POLY(ISOBUTYL 2 CYANOACRYLATE); POLYSACCHARIDE;

ANIMAL CELL; ARTICLE; CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG TARGETING; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 34249046380     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2007.01.034     Document Type: Article

References (35)

1. Bertholon I., Lesieur S., Labarre D., Besnard M., and Vauthier C. Characterization of dextran-poly(isobutylcyanoacrylate) copolymers obtained by redox radical and anionic emulsion polymerization. Macromolecules 39 (2006) 3559-3567
2. Bertholon I., Vauthier C., and Labarre D. Complement activation by core-shell poly(isobutylcyanoacrylate)-polysaccharide nanoparticles: influences of surface morphology, length, and type of polysaccharide. Pharm. Res. 23 (2006) 1313-1323
3. Bertholon I., Hommel H., Labarre D., and Vauthier C. Properties of polysaccharides grafted on nanoparticles investigated by EPR. Langmuir 22 (2006) 5485-5490
4. Calvo P., Gouritin B., Chacun H., Desmaele D., D'Angelo J., Noel J.P., Georgin D., Fattal E., Andreux J.P., and Couvreur P. Long-circulating PEGylated polycyanoacrylate nanoparticles as new carrier for brain delivery. Pharm. Res. 18 (2001) 1157-1166
5. Chauvierre, C., Couvreur, P., Labarre, D., Vauthier, C., 2002. Block-structure copolymer consisting of a saccharide segment bound to at least a biodegradable hydrophobic segment, and corresponding particles. Patent WO 0239979.
6. Chauvierre C., Labarre D., Couvreur P., and Vauthier C. Radical emulsion polymerization of alkylcyanoacrylates initiated by the redox system dextran-cerium(IV) under acidic aqueous conditions. Macromolecules 36 (2003) 6018-6027
7. Chauvierre C., Labarre D., Couvreur P., and Vauthier C. Novel polysaccharide-decorated poly(isobutylcyanoacrylate) nanoparticles. Pharm. Res. 20 (2003) 1786-1793
8. Chauvierre C., Labarre D., Couvreur P., and Vauthier C. A new approach for the characterization of insoluble amphiphilic copolymers based on their emulsifying properties. Colloid Polym. Sci. 282 (2004) 1097-1104
9. Chauvierre C., Vauthier C., Labarre D., and Hommel H. Evaluation of the surface properties of dextran-coated poly(isobutylcyanoacrylate) nanoparticles by spin-labelling coupled with electron resonance spectroscopy. Colloid Polym. Sci. 282 (2004) 1016-1025
10. Chauvierre C., Marden M.M., Vauthier C., Labarre D., Couvreur P., and Leclerc L. Heparin coated poly(alkylcyanoacrylate) nanoparticles coupled to haemoglobin: a new oxygen carrier. Biomaterials 25 (2004) 3081-3086
11. Choi Y.K., Kim Y.H., and Kim S.W. Block copolymer nanoparticles of ethylene oxide and isobutyl cyanoacrylate. Macromolecules 28 (1995) 8419-8421
12. Couvreur P., Kante B., Roland M., Guiot P., Bauduin P., and Speiser P. Polycyanoacrylate nanocapsules as potential lysosomotropic carriers: preparation, morphological and sorptive properties. J. Pharm. Pharmacol. 31 (1979) 331-332
13. Douglas S.J., Illum L., and Davis S.S. Particle size and size distribution of poly(butyl 2-cyanoacrylate) nanoparticles. II. Influence of stabilizers. J. Colloid Interf. Sci. 103 (1985) 154-163
14. ® (dt) for patients with advanced hepatocellular carcinoma (hcc). Abstract to the 12th International Symposium on Viral Hepatitis and Liver Disease. Paris, France, July 1-5, 2006. Suppl. J. Clin. Virol. 36 (suppl. 2).
15. Gref R., Minamitake Y., Peracchia M.T., Trubetskoy V., Torchilin V., and Langer R. Biodegradable long-circulating polymeric nanospheres. Science 263 (1994) 1600-1603
16. Gref R. Surface-engineered nanoparticles as drug carriers. In: Baraton M.I. (Ed). Synthesis, Functionalization and Surface Treatment of Nanoparticles (2003), American Scientific Publishers pp. 234-257 (Chapter 11)
17. Jeon S.I., Lee J.H., Andrade J.D., and De Gennes P.G. Protein-surface interactions in the presence of polyethylene oxide. J. Colloid Interf. Sci. 142 (1991) 149-158
18. Kattan J.P., Droz J., Couvreur P., Marino J.P., Boutan-Laroze A., Rougier P., Brault P., Vranks H., Grognet J.M., Morge X., and Sancho-Garnier H. Phase I clinical trial and pharmacokinetic evaluation of doxorubicin carried by polyisohexylcyanoacrylate nanoparticles. Invest. New Drug. 10 (1992) 191-199
19. Labarre D., Vauthier C., Chauvierre C., Petri B., Muller R.H., and Chehimi M.M. Interactions of blood proteins with poly(isobutylcyanoacrylate) nanoparticles decorated with a polysaccharidic brush. Biomaterials 26 (2005) 5075-5084
20. Li Y.P., Pei Y.Y., Zhou Z.H., Zhang X.Y., Gu Z.H., Ding J., Zhou J.J., Gao X.J., and Zhu J.H. Stealth polycyanoacrylate nanoparticles as tumor necrosis factor-α carriers: pharmacokinetics and anti-tumor effects. Biol. Pharm. Bull. 24 (2001) 662-665
21. Marcovich R., Williams A.L., Rubin M.A., and Wolf J.S. Comparison of 2-octyl cyanoacrylate adhesive, fibrin glue, and suturing for wound closure in the porcine urinary tract. Urology 57 (2001) 806-810
22. Moghimi S.M., Hunter A.C., and Murray J.C. Long-circulating and target-specific nanoparticles: theory to practice. Pharmacol. Rev. 53 (2001) 283-318
23. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Meth. 65 (1983) 55-63
24. Nemati F., Dubernet C., Colin de Verdière A., Poupon M.F., Treupel-Acar L., Puisieux F., and Couvreur P. Some parameters influencing cytotoxicity of free doxorubicin loaded nanoparticles in sensitive and multidrug resistant leucemic murine cells: incubation time, number of nanoparticles per cell. Int. J. Pharm. 102 (1994) 55-62
25. Passirani C., Barratt G., Devissageut J.P., and Labarre D. Long-circulating nanoparticles bearing heparin or dextran covalently bound to poly(methyl methacrylate). Pharm. Res. 15 (1998) 1046-1050
26. Peracchia M.T., Fattal E., Desmaele D., Besnard M., Gomis J.M., Appel M., D'Angelo J., and Couvreur P. Stealth PEGylated polycyanoacrylate nanoparticles for intravenous administration and splenic targeting. J. Control. Release 60 (1999) 121-128
27. Ranney D.F. Biomimetic transport and rational drug delivery. Biochem. Pharmacol. 59 (2000) 105-114
28. Soma C.E., Dubernet C., Barratt G., Nemati F., Appel M., Benita S., and Couvreur P. Ability of doxorubicin-loaded nanoparticles to overcome multidrug resistance of tumor cells after their capture by macrophages. Pharm. Res. 16 (1999) 1710-1716
29. Stella B., Arpicco S., Peracchia M.T., Desmaele D., Hoebake J., Renoir M., D'Angelo J., Cattel L., and Couvreur P. Design of folic acid-conjugated nanoparticles for drug targeting. J. Pharm. Sci. 89 (2000) 1452-1464
30. Torchillin V.P., Omelyanenko V.G., Papisov M.I., Bogdanoy A.A., Trubetskoy V.S., Herron J.N., and Gentry C.A. Poly(ethylene glycol) on the liposome surface: on the mechanism of polymer-coated liposome longevity. Biochim. Biophys. Acta 1195 (1994) 11-20
31. Toub N., Malvy C., Fattal E., and Couvreur P. Innovative nanotechnologies for the delivery of oligonucleotides and siRNA. Biomed. Pharmacother. 60 (2006) 607-620
32. Vauthier C., Dubernet C., Fattal E., Pinto-Alphandary H., and Couvreur P. Poly(alkylcyanoacrylates) as biodegradable materials for biomedical applications. Adv. Drug Deliv. Rev. 55 (2003) 519-548
33. Vonarbourg A., Passirani C., Saulnier P., and Benoit J.P. Parameters influencing the stealthiness of colloidal drug delivery systems. Biomaterials 27 (2006) 4356-4373
34. Williams Jr. R.C., and Tsay K.Y. A convenient chromatographic method for the preparation of human hemoglobin. Anal. Biochem. 54 (1973) 137-145
35. Zhang Z., Liao G., Nagai T., and Hou S. Mitoxantrone polybutyl cyanoacrylate nanoparticles as an anti-neoplastic targeting drug delivery system. Int. J. Pharm. 139 (1996) 1-8